Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Investview (INVU) Asset Writedowns and Impairment (2019 - 2024)

Historic Asset Writedowns and Impairment for Investview (INVU) over the last 6 years, with Q4 2024 value amounting to $794473.0.

  • Investview's Asset Writedowns and Impairment fell 6136.56% to $794473.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $3.8 million, marking a year-over-year decrease of 7704.05%. This contributed to the annual value of $1.8 million for FY2024, which is 1383.47% down from last year.
  • Per Investview's latest filing, its Asset Writedowns and Impairment stood at $794473.0 for Q4 2024, which was down 6136.56% from $977418.0 recorded in Q3 2024.
  • Investview's 5-year Asset Writedowns and Impairment high stood at $14.6 million for Q4 2022, and its period low was $625.0 during Q3 2022.
  • For the 5-year period, Investview's Asset Writedowns and Impairment averaged around $2.1 million, with its median value being $534438.0 (2021).
  • Per our database at Business Quant, Investview's Asset Writedowns and Impairment soared by 11041.79% in 2021 and then tumbled by 9955.43% in 2022.
  • Over the past 5 years, Investview's Asset Writedowns and Impairment (Quarter) stood at $66645.0 in 2020, then skyrocketed by 110.42% to $140233.0 in 2021, then skyrocketed by 10323.4% to $14.6 million in 2022, then plummeted by 85.93% to $2.1 million in 2023, then tumbled by 61.37% to $794473.0 in 2024.
  • Its Asset Writedowns and Impairment stands at $794473.0 for Q4 2024, versus $977418.0 for Q3 2024 and $2.1 million for Q4 2023.